Evidence map›Paper›PMID 38839909›Full record

ArticleLeukemia2024

DNA demethylating agents for chemoprevention of oncovirus-associated leukemogenesis.

Yuta Yamamoto, Tatsuro Watanabe, Hiroshi Ureshino, Yuki Kurahashi, Yuki Fukuda-Kurahashi, Kazuharu Kamachi, Kazunori Kawasoe, Keisuke Kidoguchi, Satoshi Yamashita, Naoko Hattori and 2 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Leukemia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. The Dual Role ofBiology · 2025
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yuta YamamotoDivision of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.
Tatsuro WatanabeDepartment of Drug Discovery and Biomedical Sciences, Faculty of Medicine, Saga University, Saga, Japan.ORCID 0000-0002-4166-4781
Hiroshi UreshinoDivision of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.ORCID 0000-0002-5034-3699
Yuki KurahashiDepartment of Drug Discovery and Biomedical Sciences, Faculty of Medicine, Saga University, Saga, Japan.
Yuki Fukuda-KurahashiDepartment of Drug Discovery and Biomedical Sciences, Faculty of Medicine, Saga University, Saga, Japan.
Kazuharu KamachiDivision of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.
Kazunori KawasoeDivision of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.
Keisuke KidoguchiDivision of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.
Satoshi YamashitaDepartment of Life Engineering, Faculty of Engineering, Maebashi Institute of Technology, Maebashi, Japan.
Naoko HattoriDepartment of Epigenomics, Institute for Advanced Life Sciences, Hoshi University, Shinagawa City, Japan.
Toshikazu UshijimaDepartment of Epigenomics, Institute for Advanced Life Sciences, Hoshi University, Shinagawa City, Japan.ORCID 0000-0003-3405-7817
Shinya KimuraDivision of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan. shkimu@cc.saga-u.ac.jp.ORCID 0000-0003-1717-6208

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DNA MethylationAnimalsAzacitidineCarcinogenesisChemopreventionHumansLeukemiaMiceAzacitidine

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.